These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

141 related items for PubMed ID: 3087677

  • 1. Enprostil, in contrast to cimetidine, does not inhibit propranolol metabolism.
    Reilly CS, Biollaz J, Koshakji RP, Wood AJ.
    Clin Pharmacol Ther; 1986 Jul; 40(1):37-41. PubMed ID: 3087677
    [Abstract] [Full Text] [Related]

  • 2. Reduction of liver blood flow and propranolol metabolism by cimetidine.
    Feely J, Wilkinson GR, Wood AJ.
    N Engl J Med; 1981 Mar 19; 304(12):692-5. PubMed ID: 7464861
    [Abstract] [Full Text] [Related]

  • 3. [Efficacy and tolerability of enprostil in the treatment of duodenal ulcer. Comparison with cimetidine].
    Frexinos J, Andrieu J, Evreux M, Guerre J, Michel H, Vicari F, Joubert M.
    Gastroenterol Clin Biol; 1989 Mar 19; 13(2):188-92. PubMed ID: 2496000
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Enprostil. A preliminary review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in the treatment of peptic ulcer disease.
    Goa KL, Monk JP.
    Drugs; 1987 Nov 19; 34(5):539-59. PubMed ID: 3121276
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Reduction of serum lipoproteins in man by the oral administration of a prostaglandin analogue (enprostil).
    Schwartz KE, Zaro B, Burton P, Hunt J, Pennelly L, Sevelius H.
    Atherosclerosis; 1988 May 19; 71(1):9-16. PubMed ID: 3132181
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Enprostil, a prostaglandin E2 analogue, in the treatment of duodenal ulcer; a multicentre comparison with cimetidine.
    Jazrawi RP, Northfield TC, Reed PI, Cockel R, Schillers KF, Barkers ES.
    Aliment Pharmacol Ther; 1988 Aug 19; 2(4):353-9. PubMed ID: 2979259
    [Abstract] [Full Text] [Related]

  • 12. Effects of cimetidine and ranitidine on steady-state propranolol kinetics and dynamics.
    Reimann IW, Klotz U, Frölich JC.
    Clin Pharmacol Ther; 1982 Dec 19; 32(6):749-57. PubMed ID: 6291839
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Acute and chronic effects of oral enprostil, a synthetic dehydroprostaglandin E2, on uterine contractility.
    Pulkkinen MO.
    Prostaglandins Leukot Essent Fatty Acids; 1989 Apr 19; 36(1):15-9. PubMed ID: 2500670
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Pharmacokinetic drug interactions with propranolol.
    Wood AJ, Feely J.
    Clin Pharmacokinet; 1983 Apr 19; 8(3):253-62. PubMed ID: 6342901
    [Abstract] [Full Text] [Related]

  • 20. Suppression of postprandial glucose, insulin, C-peptide, and glucose-dependent insulinotropic peptide (GIP) in man by oral administration of a prostaglandin analogue (enprostil).
    Schwartz KE, Zaro B, Reynolds J, Duffy J, Saito T, Hunt JS, Sevelius H.
    Horm Metab Res; 1988 Oct 19; 20(10):637-40. PubMed ID: 3146539
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.